Synchrony Financial: 2Q26 Earnings Review: Path to MSD Loan Growth Remains Well Underway

Research evidence excerpt

Synchrony Financial: 2Q26 Earnings Review: Path to MSD Loan Growth Remains Well Underway

Equity Research

U.S. Consumer Finance

22 July 2026

Synchrony Financial

2Q26 Earnings Review: Path to

MSD Loan Growth Remains Well

SYF OVERWEIGHTUnderway

Unchanged

EPS beat on a reserve release, but PPNR missed modestly as U.S. Consumer Finance NEUTRAL

NII and opex were worse than expectations. Total loan growth Unchanged

of 2.4% y/y was solid, with Digital and Diversified & Value Price Target USDUnchanged93.00

platforms showing meaningful accelerations. Price (21-Jul-26) USD 72.21

Potential Upside/Downside +28.8%

Source: Bloomberg, Barclays Research

The Key Takeaway: There were puts and takes this quarter. Investor focus was centered on the

PPNR miss (3.6% vs. Barc) and a revised EPS guide that implied 2H earnings approximately 8%

Market Cap (USD mn) 24331lower than current Street expectations at the midpoint. However, we believe the delta reflects

Shares Outstanding (mn) 336.95the pull forward of the reserve release into 2Q. Taking a step back, credit remains solid and loan

Free Float (%) 99.48growth improved sequentially on a y/y basis. At the platform level, the Digital and Diversified &

52 Wk Avg Daily Volume (mn) 3.8Value platforms delivered a strong acceleration in purchase volume, receivables, and account

Dividend Yield (%) 1.88growth in the quarter. We expect growth momentum to continue to build in the following

Return on Equity TTM (%) 22.25months, and view the average accounts inflecting positive as a good sign for 2H's growth. With

Current BVPS (USD) 46.67shares trading at ~6.9x (compared to the historical average of 8x) we view the risk/reward

Source: Bloomberg

favorably.

Results: SYF reported 2Q26 EPS of $2.59, compared to BARC ($2.11) and Street ($2.12).